Yasmin M Abaza (Yasmin Abaza)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 34

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

African American

Top Venues

American journal of hematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand Ashwin Patel, Caner Saygin, Amer M Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F Zeidner, Catherine C Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A Griffiths, Monzr M Al Malki, Idoroenyi Amanam, Catherine E Lai, H Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf E G Osman, Shira Naomi Dinner, Yasmin M Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mirinal S Patnaik, Luca Malcovati, Michael R Savona, Aref A Al-Kali
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence. Blood (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence J Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology (2024)
Yi Wang, Andrés E Quesada, Zhuang Zuo, L Jeffrey Medeiros, Cheng Cameron Yin, Shaoying Li, Jie Xu, Gautam Borthakur, Yisheng Li, Chao Yang, Yasmin M Abaza, Juehua Gao, Xinyan Lu, M James You, Yizhuo Zhang, Pei Lin
The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation. Cancers 15 (1) (2022)
Yi Wang, Andrés E Quesada, Zhuang Zuo, L Jeffrey Medeiros, Cheng Cameron Yin, Shaoying Li, Jie Xu, Gautam Borthakur, Yisheng Li, Chao Yang, Yasmin M Abaza, Juehua Gao, Xinyan Lu, M James You, Yizhuo Zhang, Pei Lin
The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation. Cancers 15 (1) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Yi Wang, Andrés E Quesada, Zhuang Zuo, L Jeffrey Medeiros, Cheng Cameron Yin, Shaoying Li, Jie Xu, Gautam Borthakur, Yisheng Li, Chao Yang, Yasmin M Abaza, Juehua Gao, Xinyan Lu, M James You, Yizhuo Zhang, Pei Lin
The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation. Cancers 15 (1) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer (2022)
Yi Wang, Andrés E Quesada, Zhuang Zuo, L Jeffrey Medeiros, Cheng Cameron Yin, Shaoying Li, Jie Xu, Gautam Borthakur, Yisheng Li, Chao Yang, Yasmin M Abaza, Juehua Gao, Xinyan Lu, M James You, Yizhuo Zhang, Pei Lin
The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation. Cancers 15 (1) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Yasmin M Abaza, Amer M Zeidan
Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Cells 11 (14) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Yasmin M Abaza, Hagop M Kantarjian, Yasmin Alwash, Gautam Borthakur, Richard Champlin, Tapan Mahendra Kadia, Guillermo Garcia-Manero, Naval G Daver, Farhad Ravandi, Srdan Verstovsek, Jan Burger, Zeev Estrov, Maro Ohanian DO, Miranda Lim, Naveen Pemmaraju, Elias J Jabbour, Jorge E Cortes
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia. American journal of hematology 95 (11) (2020)
Yasmin M Abaza, Jorge Cortes, Farhad Ravandi, Tapan Mahendra Kadia, Guillermo Garcia-Manero, Naveen Pemmaraju, Aditya Shetty, Sherry Pierce, Wei Qiao, Hagop M Kantarjian, Gautam Borthakur
Prognostic significance of hyperdiploidy in adult acute myeloid leukemia. American journal of hematology 93 (11) (2018)
Yasmin M Abaza, Hagop M Kantarjian, Stefan Faderl, Elias J Jabbour, Nitin Jain, Deborah Thomas, Tapan Mahendra Kadia, Gautam Borthakur, Joseph D Khoury, Jan Burger, William Wierda, Susan O'Brien, Marina Konopleva, Alessandra Ferrajoli, Partow Kebriaei, Bouthaina Dabaja, Steven Kornblau, Yesid Alvarado, Naval Daver, Naveen Pemmaraju, Prithviraj Bose, Philip Thompson, Hind Al Azzawi, Mary Kelly, Rebecca Garris, Preetesh Jain, Guillermo Garcia-Manero, Jorge Cortes, Farhad Ravandi
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. American journal of hematology 93 (1) (2017)
Yasmin M Abaza, Tapan Mahendra Kadia, Elias J Jabbour, Marina Y Konopleva, Gautam Borthakur, Alessandra Ferrajoli, Zeev Estrov, William G Wierda, Ana Alfonso, Toh Han Chong, Charles Chuah, Liang-Piu Koh, Boon-Cher Goh, Julie E Chang, Daniel E Durkes, Maria Cielo Foudray, Hagop M Kantarjian, Xiao Qin Dong, Guillermo Garcia-Manero
Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies. Cancer 123 (24) (2017)
Yasmin M Abaza, Hagop M Kantarjian, Guillermo Garcia-Manero, Elihu H Estey, Gautam Borthakur, Elias Jabbour, Stefan Faderl, Susan O'Brien, William Wierda, Sherry Pierce, Mark Brandt, Deborah McCue, Rajyalakshmi Luthra, Keyur Patel, Steven Kornblau, Tapan Kadia, Naval Daver, Courtney DiNardo, Nitin Jain, Srdan Verstovsek, Alessandra Ferrajoli, Michael Andreeff, Marina Konopleva, Zeev Estrov, Maria Foudray, David McCue, Jorge Cortes, Farhad Ravandi
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood 129 (10) (2016)